Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma
Veterinary and Comparative Oncology · 2024-09 · 22 (3) · 437-446
DOI: 10.1111/vco.12995 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 15.07.2024. Verfasst von Nicolas Diop und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lyon, VetAgro Sup, Service de cancérologie, UR ICE, Marcy l'Etoile, France. Hauptthemen laut MEDLINE: Electrochemotherapy, Bleomycin, Skin Neoplasms, Cat Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Dans les Yeux d'Hulk.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Electrochemotherapy (ECT) with intravenous (IV) and/or intratumoral (IT) bleomycin has shown considerable efficacy in the treatment of non‐resectable feline cutaneous squamous cell carcinoma (cSCC), boasting response rates of up to 95%, but other chemotherapy protocols have not yet been investigated. The objective of this prospective multicentre study was to compare the overall response rate (ORR) and progression‐free interval (PFI) between cats with cSCC treated with ECT using IT and IV carboplatin (IV + IT), IV carboplatin (IV) or IV bleomycin (IV). A total of 44 cats with unresectable cSCC across three centres were enrolled and treated with ECT using carboplatin IV + IT ( n = 10), carboplatin IV ( n = 11) or bleomycin IV ( n = 23). Treatment response according to RECIST criteria was recorded at 2 and 4 weeks post‐treatment, and patients were followed until disease progression and/or death. All three groups were comparable regarding age, sex, weight, and lesion size. Adverse events were generally mild, localised and similar between groups. ORRs were 90.0% (carboplatin IV + IT), 90.9% (carboplatin IV) and 95.6% (bleomycin IV) and were not significantly different ( p = 0.79). Median PFI was not reached for carboplatin IV + IT or carboplatin IV and was 566 days for bleomycin IV, with no significant difference between the three groups ( p = 0.81). This study suggests that ECT using IV or IV + IT carboplatin is a reasonable alternative therapeutic option for managing cSCC, and further studies are warranted to compare outcomes between treatment protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Lyon, VetAgro Sup, Service de cancérologie, UR ICE, Marcy l'Etoile, France.
- ONCOnseil-Unité d'expertise en oncologie vétérinaire, Toulouse, France.
- AniCura TRIOVet, Rennes, France.
ORCID-Profile: Nicolas Diop, David Sayag
Förderung
- Association Dans les Yeux d'Hulk
Zitieren
APA
Diop, N., Sayag, D., Marques, G. B., Chamel, G., Chavalle, T., Eon, J. B., Floch, F., Lajoinie, M., Ponce, F., & Barrett, L. E. (2024). Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma. Veterinary and Comparative Oncology, 22(3), 437-446. https://doi.org/10.1111/vco.12995
Vancouver
Diop N, Sayag D, Marques GB, Chamel G, Chavalle T, Eon JB, et al. Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma. Veterinary and Comparative Oncology. 2024;22(3):437-446. doi:10.1111/vco.12995
BibTeX
@article{Diop2024,
author = {Diop, Nicolas and Sayag, David and Marques, Grégoire Bernardo and Chamel, Gabriel and Chavalle, Thomas and Eon, Jean-Bapiste and Floch, Franck and Lajoinie, Mathilde and Ponce, Frédérique and Barrett, Laura E},
title = {Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma},
journal = {Veterinary and Comparative Oncology},
year = {2024},
volume = {22},
number = {3},
pages = {437--446},
doi = {10.1111/vco.12995}
}
EUVIMED